"Liver" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
| Descriptor ID |
D008099
|
| MeSH Number(s) |
A03.620
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Liver".
Below are MeSH descriptors whose meaning is more specific than "Liver".
This graph shows the total number of publications written about "Liver" by people in this website by year, and whether "Liver" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 9 | 12 | 21 |
| 1996 | 5 | 15 | 20 |
| 1997 | 11 | 8 | 19 |
| 1998 | 6 | 11 | 17 |
| 1999 | 8 | 14 | 22 |
| 2000 | 3 | 14 | 17 |
| 2001 | 13 | 13 | 26 |
| 2002 | 10 | 15 | 25 |
| 2003 | 8 | 15 | 23 |
| 2004 | 9 | 20 | 29 |
| 2005 | 14 | 20 | 34 |
| 2006 | 19 | 17 | 36 |
| 2007 | 8 | 14 | 22 |
| 2008 | 13 | 20 | 33 |
| 2009 | 10 | 13 | 23 |
| 2010 | 11 | 17 | 28 |
| 2011 | 10 | 14 | 24 |
| 2012 | 5 | 9 | 14 |
| 2013 | 13 | 12 | 25 |
| 2014 | 13 | 11 | 24 |
| 2015 | 18 | 17 | 35 |
| 2016 | 19 | 10 | 29 |
| 2017 | 17 | 14 | 31 |
| 2018 | 9 | 13 | 22 |
| 2019 | 12 | 9 | 21 |
| 2020 | 10 | 9 | 19 |
| 2021 | 10 | 15 | 25 |
| 2022 | 3 | 22 | 25 |
| 2023 | 2 | 22 | 24 |
| 2024 | 3 | 8 | 11 |
| 2025 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver" by people in Profiles.
-
GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic ß-cell function in obese male mice. Nat Commun. 2025 May 21; 16(1):4714.
-
Assessment of Liver Fibrosis Through Shear Wave Elastography in Pediatric Liver Transplant Recipients. Pediatr Transplant. 2025 May; 29(3):e70056.
-
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. N Engl J Med. 2025 Jun 05; 392(21):2089-2099.
-
Liver-targeted allergen immunotherapy rapidly and safely induces antigen-specific tolerance to treat allergic airway disease in mice. Sci Transl Med. 2025 Apr 16; 17(794):eadl0406.
-
Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studies. Sci Rep. 2024 12 30; 14(1):31826.
-
Integrative Protocol for Generation of iPSC-Derived 3D Human Hepatic Organoids. J Vis Exp. 2024 Dec 06; (214).
-
LI-RADS US Surveillance Version 2024 for Surveillance of Hepatocellular Carcinoma: An Update to the American College of Radiology US LI-RADS. Radiology. 2024 Dec; 313(3):e240169.
-
Semaglutide 2.4?mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial. Aliment Pharmacol Ther. 2024 Dec; 60(11-12):1525-1533.
-
Body composition and muscle composition phenotypes in patients on waitlist and shortly after liver transplant - results from a pilot study. BMC Gastroenterol. 2024 Oct 09; 24(1):356.
-
Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma. JAMA. 2024 09 24; 332(12):1013-1014.